Results 281 to 290 of about 129,510 (314)

Circulating extracellular vesicles predict outcome in patient undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. [PDF]

Sci Rep
Loosen SH, Hansen FJ, Schatilow D, Wirtz T, Reuken PA, Bode J, Kunstein A, Vucur M, Reißing J, Flügen G, Castoldi M, Stallmach A, Luedde T, Bruns T, Roderburg C.   +14 more
europepmc   +1 more source

Table 1_Urokinase-type plasminogen activator deficiency enhances CD8+ T cell infiltration and anti-PD-1 therapy efficacy in prostate cancer.xlsx

Xiaoyi Li (669720), Xiao Zhang (152326), Xing Fu (42224), Hong Wu (105254), Xinyu Ye (401069), Xin Huang (11077), Yuhao Cui (22152538), Chao-Nan Qian (248097), Yi Lu (6211), Jian Zhang (1682)   +9 more
openalex   +1 more source

Factors affecting the early efficacy of intravenous thrombolysis using alteplase in acute ischemic stroke: A retrospective analysis of 255 cases. [PDF]

Medicine (Baltimore)
Cheng J, Yuan Z, Zeng Y, Hou Y, Zhang Y.
europepmc   +1 more source

Global research trends and therapeutic potential of fibrinolytic enzymes. [PDF]

J Genet Eng Biotechnol
Hazare C, Bhagwat P, Singh S, Pillai S.
europepmc   +1 more source

Correction: Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke. [PDF]

J Med Ultrason (2001)
Kaburagi K, Shimizu T, Hagiwara Y, Fukano T, Shibata S, Hoshino M, Sasaki N, Akiyama H, Hasegawa Y, Yamano Y.   +9 more
europepmc   +1 more source

The Role of Blood-Brain Barrier Disruption in Epilepsy: Mechanisms and Consequences. [PDF]

Neurol Int
Suleymanova E, Karan A.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effects of Fluvastatin and Bezafibrate Combination on Plasma Fibrinogen, t-plasminogen Activator Inhibitor and C Reactive Protein Levels in Coronary Artery Disease Patients with Mixed Hyperlipidaemia (FACT Study)

Thrombosis and Haemostasis, 2000
SummaryWe studied the effects of fluvastatin and bezafibrate in monotherapy and in combination on plasma fibrinogen, t-plasminogen activator inhibitor (PAI-1) and C reactive protein (CRP) in patients with coronary artery disease (CAD) and mixed hyperlipidaemiaIn this randomised, double blind, multicentre trial 333 patients with stable angina pectoris ...
R. Paoletti, M. Mariani, M. Mancini, F. Cortellaro, C. Boschetti, E. Cofrancesco, M. Cortellaro   +6 more
openaire   +1 more source

Effects of Fluvastatin and Bezafibrate Combination on Plasma Fibrinogen, t-Plasminogen Activator Inhibitor and C Reactive Protein Levels in Coronary Artery Disease Patients with Mixed Hyperlipidaemia (FACT Study) – A Rebuttal

Thrombosis and Haemostasis, 2001
Effects of Fluvastatin and Bezafibrate Combination on Plasma Fibrinogen, t-Plasminogen Activator Inhibitor and C Reactive Protein Levels in Coronary Artery Disease Patients with Mixed Hyperlipidaemia (FACT Study) – A Rebuttal -
openaire   +2 more sources